Technical Analysis for AQST - Aquestive Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.11 -3.42% -0.11
AQST closed down 3.42 percent on Friday, September 20, 2019, on 1.61 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AQST trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -3.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -10.89%

Older signals for AQST ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. Libervant is a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures. Sympazan is an oral soluble film formulation of clobazam for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut Syndrome. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The Company’s complex molecule programs consist of AQST-108, and AQST-305, for the treatment of anaphylaxis and neuroendocrine tumors respectively. The Company also has a pipeline of products under partner programs, which includes Suboxone and APL-130277 for the treatment of opioid dependence, and Parkinson’s disease.
Pharmaceutical Diseases Drugs Psychoactive Drugs Amyotrophic Lateral Sclerosis Epilepsy Chloroarenes Opioids Gabaa Receptor Positive Allosteric Modulators Lactams Parkinson’s Disease Neuroendocrine Tumors Riluzole
Is AQST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.49
52 Week Low 2.96
Average Volume 92,702
200-Day Moving Average 5.51
50-Day Moving Average 3.6998
20-Day Moving Average 3.6155
10-Day Moving Average 3.439
Average True Range 0.3057
ADX 18.81
+DI 12.8878
-DI 25.0047
Chandelier Exit (Long, 3 ATRs ) 3.4529
Chandelier Exit (Short, 3 ATRs ) 3.9971
Upper Bollinger Band 4.0842
Lower Bollinger Band 3.1468
Percent B (%b) -0.04
BandWidth 25.927258
MACD Line -0.1298
MACD Signal Line -0.0887
MACD Histogram -0.0411
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.53
Resistance 3 (R3) 3.58 3.48 3.46
Resistance 2 (R2) 3.48 3.38 3.46 3.44
Resistance 1 (R1) 3.30 3.31 3.25 3.25 3.41
Pivot Point 3.20 3.20 3.18 3.18 3.20
Support 1 (S1) 3.02 3.10 2.97 2.97 2.81
Support 2 (S2) 2.92 3.03 2.90 2.78
Support 3 (S3) 2.74 2.92 2.76
Support 4 (S4) 2.69